NASDAQ: SPRY - ARS Pharmaceuticals, Inc.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -0.571
CAGR EPS = 17.44%
Key Rate = 0.0458
Excess Key Rate = 2
Price = 8.67 + (8.67 * 17.44% / 100) = 10.18

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -0.1653
Ebitda Yield = 0.1964
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.000834
Debt = 0.000274
Market Cap = 0.6729
Weight Debt = Market Cap / (Market Cap + Debt) = 0.6729 / (0.6729 + 0.000274) = 0.9996
Weight Cost Debt = 100% - 0.9996 = 0.00039999999999996
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = 7.15
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + 7.15 * 5.94 + 0 = 0.4506
WACC = (0.000834 / 0.000274) * (100% - 0.9996) * (1 - 0.21) + 0.4506 + 0.9996 = 238.51
Terminal Value = Discount (-0.1653 * (1 + 0.1964) / (238.51 - 0.1964)) = -0.000203
Company Value = ∑ (-0.1653 / (1 + 238.51) ^ 5) = -0.0367
Price = (Terminal Value + Company Value) / Count shares = (-0.000203 + -0.0367) / 95220000 = -0.3872

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = -0.151
FCF Yield = 0.205
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.000834
Debt = 0.000274
Market Cap = 0.6729
Weight Debt = Market Cap / (Market Cap + Debt) = 0.6729 / (0.6729 + 0.000274) = 0.9996
Weight Cost Debt = 100% - 0.9996 = 0.00039999999999996
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = 7.15
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + 7.15 * 5.94 + 0 = 0.4506
WACC = (0.000834 / 0.000274) * (100% - 0.9996) * (1 - 0.21) + 0.4506 + 0.9996 = 238.51
Terminal Value = Discount (-0.151 * (1 + 0.205) / (238.51 - 0.205)) = -0.000188
Company Value = ∑ (-0.151 / (1 + 238.51) ^ 5) = -0.0327
Price = (Terminal Value + Company Value) / Count shares = (-0.000188 + -0.0327) / 95220000 = -0.345